2-Methylpyrrolidine → HCID 71557568, compound
Reaction equation
C(C1N=C(N2CCOCC2)C2N=NN([CH2:14][C:15]3[CH:20]=[CH:19][CH:18]=C[C:16]=3Cl)C=2N=1)(C)(C)C.[C:28]([C:32]1[N:33]=[C:34](Cl)[C:35]2[N:40]=[N:39][N:38]([CH2:41][C:42]3[CH:47]=[CH:46][CH:45]=[CH:44][C:43]=3[Cl:48])[C:36]=2[N:37]=1)([CH3:31])([CH3:30])[CH3:29].CC1CCC[NH:52]1>>[C:28]([C:32]1[N:33]=[C:34]([N:52]2[CH2:18][CH2:19][CH2:20][C:15]2([CH3:14])[CH3:16])[C:35]2[N:40]=[N:39][N:38]([CH2:41][C:42]3[CH:47]=[CH:46][CH:45]=[CH:44][C:43]=3[Cl:48])[C:36]=2[N:37]=1)([CH3:31])([CH3:30])[CH3:29]Participants
4
Procedure
In analogy to the procedure described for the synthesis of 5-tert-butyl-3-(2-chloro-benzyl)-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidine (example 1, step c), the title compound was prepared from 5-tert-butyl-7-chloro-3-(2-chlorobenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine and 2-methylpyrrolidine and isolated as white solid (13.2 mg, 70%). MS (m/e): 399.4 (MH+).
Sources & evidence
- ORD record
- ord-a919ab41def544dca7cc3b0ab58bc89e
- Source dataset
- uspto-grants-2014_06
- Patent number
- US08741906B2
Reaction notes
Loading…